Watch our latest webinar!
Spotlight on Familial hypercholesterolemia (FH) – Uncovering the importance of genetic testing.
Insight and inspiration
News | January 17, 2024
Devyser Genomic Laboratories signs first commercial agreement
Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first commercial agreement with UK based diagnostics company Cyted.Find out more
News | January 15, 2024Devyser wins tender for cystic fibrosis in Italy
News | Jan 08, 2024Devyser signs in vitro diagnostic agreement with Illumina to broaden access to its tests
News | December 12, 2023Devyser wins tender for non-invasive fetal RHD testing in Wales
Latest from the Devyser blogView all
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Early detection of relapse and early therapeutic intervention: The benefits of Devyser NGS method for chimerism analysis
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Devyser enters agreement with Thermo Fisher Scientific for commercialization of Devyser’s post-transplant NGS products
Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...